Dr. Kashkin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
23-00 State Rt 208
Ste 2
Fair Lawn, NJ 07410Phone+1 201-794-7400Fax+1 201-475-9669
Summary
- Dr. Jay Kashkin is an allergist/immunologist in Fair Lawn, NJ and is affiliated with Valley Hospital. He received his medical degree from CETEC University Santo Domingo and has been in practice 31years.
Dr. Kashkin is a former assistant clinical professor of pediatrics in the division of allergy and clinical immunology at the Albert Einstein College of Medicine. He performed research looking at fetal target organs of HIV and was a principle investigator studying the use of IVIG to possibly mitigate the progression of the immune deficiency in asymptomatic HIV infected children.
He also speaks multiple languages, including Spanish. He specializes in asthma, primary immunodeficiencies, chronic idiopathic urticaria and allergic conditions in infants, children and adults. Dr Kashkin is a national thought leader and researcher in the field of hereditary angioedema and lectures nationally and conducts research and publishes on the topic of HAE.
Education & Training
- Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Allergy and Immunology, 1986 - 1988
- Jacobi Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 1984 - 1986
- Maimonides Medical Center/Infants and Children's Hospital of BrooklynInternship, Pediatrics, 1983 - 1984
- CETEC University Santo DomingoClass of 1983
Certifications & Licensure
- NJ State Medical License 1988 - 2025
- PA State Medical License 1988 - 2007
- PediatricsAmerican Board of Pediatrics
Awards, Honors, & Recognition
- Super Docs 2012-2022
- Super Docs 201 Magazine Health Edition, 2012-2022
- Award Recipient Bergen County Public Health Service Award, 2010
- Join now to see all
Clinical Trials
- A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II in North America Start of enrollment: 2019 Mar 30
- A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) Start of enrollment: 2020 May 04
- Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks Start of enrollment: 2021 Mar 29
Publications & Presentations
PubMed
- 10 citationsBerotralstat (BCX7353) is a novel oral prophylactic treatment for hereditary angioedema: Review of phase II and III studiesMichael E Manning, Jay M Kashkin
Allergy and Asthma Proceedings. 2021-06-14 - 21 citationsUpdate on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema.H. Henry Li, Marc A. Riedl, Jay M. Kashkin
Clinical Reviews in Allergy & Immunology. 2019-04-01 - 18 citationsLong-term prophylaxis therapy in patients with hereditary angioedema with C1 inhibitor deficiencyTimothy J. Craig, Paula J. Busse, Richard G. Gower, Douglas T. Johnston, Jay M. Kashkin
Annals of Allergy, Asthma & Immunology. 2018-12-01
Journal Articles
- Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary AngioedemaMarc Riedl, Jay Kashkin, Clinical Reviews in Allergy & Immunology
Authored Content
- Berotralstat BCX7353 is a novel oral prophylactic treatment for hereditary angioedema: Review of phase II and II studiesJune 2021
Committees
- National Lecturer: Takeda, Pharming, CSL Behring, BioCryst, National Speakers Bureau on HAE Diagnosis and Therapeutics 2007 - 2021
- Bergen County Dept of Health, Asthma Education Board 2005 - 2009
- Board Member, American Lung Association 1989 - 2002
Research History
- Principle InvestigatorDyax Sponsored Study Biomarkers in Serum of Patients with HAE Type I and II.2014 - Present
- Principle investigatorIVIG in asymptomatic HIV infected children. The Albert Einstein College of Medicine1988 - 1990
Professional Memberships
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: